Male n(%) |
125 (79.1%) |
33 (70%) |
0.18 |
Female n(%) |
33 (20.9%) |
15 (30%) |
0.18 |
Age (years) |
60± 11 |
66±8 |
<0.001 |
Height (cm) |
169 ± 8 |
169±10 |
0.92 |
Weight (Kg) |
80.4±14.6 |
81.1±12.7 |
0.74 |
BMI (kg/m2 ) |
27.8±4.3 |
28.3±3.5 |
0.50 |
BSA ( m2 ) |
1.9±0.1 |
1.9±0.1 |
0.73 |
Beta blockers n(%) |
90 (7.3%) |
33 (67.3%) |
0.21 |
Pre-operative antiarrhythmic drugs n(%) |
7 (4.5%) |
9 (18.4%) |
<0.001 |
Hypertension n(%) |
94 (59.5%) |
37 (74%) |
0.06 |
Diabetes Mellitus treated with insulin n(%) |
31 (19.6%) |
6 (12%) |
0.21 |
Diabetes Mellitus not treated with insulin n(%) |
39 (24.7%) |
11
(22%) |
0.69 |
Dyslipidemia n(%) |
105 (66.5%) |
32 (64%) |
0.75 |
COPD and Interstitial lung disease n(%) |
7 (4.4%) |
1 (2%) |
0.43 |
Peripheral Vascular Disease n(%) |
5 (3.2%) |
1 (2%) |
0.66 |
Renal failure n(%) |
5 (3.2%) |
3 (6.1%) |
0.34 |
Patients undergoing dialysis n(%) |
2 (1.3%) |
0 (0%) |
0.43 |
Permanent pacemaker n(%) |
3 (1.9%) |
1 (2%) |
0.96 |
Previous CVA n(%) |
7 (4.4%) |
7 (14%) |
0.01 |
Previous TIA n(%) |
1 (0.6%) |
1 (2%) |
0.38 |
Coronary Vascular disease n(%) |
97 (61.4%) |
32 (64%) |
0.74 |
Chronic heart failure n(%) |
8 (5.1%) |
4 (8%) |
0.44 |
Ejection Fraction (%) |
53.6 ± 16.3 |
52.5 ±23.6 |
0.35 |
Previous CABG n(%) |
3 (1.9%) |
2 (4%) |
0.39 |
Prior Valve Replacement n(%) |
3 (1.9%) |
5 (10%) |
<0.001 |
Prior PCI n(%) |
43 (27.2%) |
16 (32%) |
0.51 |